17 research outputs found

    Characteristics of the study population.

    No full text
    <p>*Standard matching algorithm: includes subsequent participants in ‘KardioPro’ as control subjects.</p>†<p>Sensitivity analysis – modified matching algorithm: excludes subsequent participants in ‘KardioPro’ as control subjects.</p><p>SD: standard deviation.</p><p>CHD: coronary heart disease.</p><p>Characteristics of the study population.</p

    Results of time-to-event analysis.

    No full text
    <p>CI: confidence interval.</p><p>*As the time under observation of fatal and non-fatal events differs, the number of deaths and the number of non-fatal events do not sum to the number of events of the combined endpoint.</p><p>Results of time-to-event analysis.</p

    Effect of ‘KardioPro’ on elective<sup>*</sup> interventions (McNemar tests).

    No full text
    <p>*Elective: interventions that did not take place on the day of a myocardial infarction.</p><p>Effect of ‘KardioPro’ on elective<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0114720#nt107" target="_blank">*</a></sup> interventions (McNemar tests).</p

    Stent Thrombosis.

    No full text
    <p>Values are n of events (%). CI = confidence interval, OR = odds ratio, RI = renal impairment.</p><p>Stent Thrombosis.</p

    Angiographic Surveillance Findings.

    No full text
    <p>Values are mean (SD) unless specified. CI = confidence interval, OR = odds ratio, MLD = minimal lumen diameter, RI = renal impairment.</p><p>Angiographic Surveillance Findings.</p

    Angiographic and Procedural Characteristics at Baseline.

    No full text
    <p>Values are means (SD) or n (%). RVD = reference vessel diameter, MLD = minimal lumen diameter, RI = renal impairment.</p><p>Angiographic and Procedural Characteristics at Baseline.</p

    Predicted Risk of Adverse Clinical Outcomes According to Renal Function.

    No full text
    <p>Crude and adjusted predicted 2-year odds ratios for the composite of cardiac death and myocardial infarction (left) and target-lesion revascularization (right) at different levels of baseline glomerular filtration rate (GFR), using 90 ml/min as reference.</p
    corecore